This new therapeutic, DISC-0974, exhibits high selectivity for RGMC, this vital protein involved with embryonic differentiation. Initial results suggest that inhibiting RGMC/HFE2 signaling with DISC-0974 therapeutic https://www.targetmol.com/compound/disc_0974